Induced pluripotent stem (iPS) cells are derived by epigenetic reprogramming, but their DNA methylation patterns
have not yet been analyzed on a genome-wide scale. Here, we find substantial hypermethylation and hypomethylation of cytosine-phosphate-guanine (CpG) island shores in nine human iPS cell lines as compared to their parental fibroblasts. The differentially methylated regions (DMRs) in the reprogrammed cells (denoted R-DMRs) were significantly enriched in tissue-specific (T-DMRs; 2.6-fold, P < 10 -4 ) and cancer-specific DMRs (C-DMRs; 3.6-fold, P < 10 -4 ). Notably, even though the iPS cells are derived from fibroblasts, their R-DMRs can distinguish between normal brain, liver and spleen cells and between colon cancer and normal colon cells. Thus, many DMRs are broadly involved in tissue differentiation, epigenetic reprogramming and cancer. We observed colocalization of hypomethylated R-DMRs with hypermethylated C-DMRs and bivalent chromatin marks, and colocalization of hypermethylated R-DMRs with hypomethylated C-DMRs and the absence of bivalent marks, suggesting two mechanisms for epigenetic reprogramming in iPS cells and cancer.
Induced pluripotent stem (iPS) cells can be derived from somatic cells by introduction of a small number of genes: for example, POU5F1, MYC, KLF4 and SOX2 [1] [2] [3] [4] . As direct derivatives of an individual's own tissue, iPS cells offer considerable therapeutic promise 5 , avoiding both immunologic and ethical barriers to their use. iPS cells differ from their somatic parental cells epigenetically, and thus a com prehensive comparison of the epigenome in iPS and somatic cells would provide insight into the mechanism of tissue reprogramm ing. Although two recent targeted studies 6,7 examined a subset of the genome-7,000 (ref. 6 ) and 66,000 (ref. 7) CpG sites-in a small cohort of three iPSfibroblast pairs, a global assessment of genomewide methylation has not yet been performed.
Recently, we described differential methylation patterns that dis tinguish among normal tissue types (TDMRs) and patterns that can segregate colorectal cancer tissue from matched normal tissues (CDMRs) 8 . Unexpectedly, these two DMRs occur 13fold more frequently at CpG island 'shores', regions of comparatively low CpG density that are located near traditional CpG islands, than at the CpG islands themselves. Cancers showed approximately equal num bers of hypomethylated and hypermethylated regions, and 45% of CDMRs overlapped TDMRs, suggesting that epigenetic changes in cancer involve reprogramming of the normal pattern of tissue specific differentiation 8 .
Here we used a similar approach to the question of iPS cell reprogramming, first comparing six human iPS cell lines to the fibroblasts from which they were derived using comprehensive high throughput arraybased relative methylation (CHARM) analysis 9 . This approach allows the interrogation of ~4.6 million CpG sites genomewide using a custom designed NimbleGen HD2 microarray, including almost all CpG islands and shores in the human genome. Genomic DNA from iPS cells 3, 5 , their parental fibroblasts and human embryonic stem (hES) cells (Online Methods) was digested with the enzyme McrBC, fractionated, labeled and hybridized to a CHARM array.
A total of 4,401 regions (including 96,404 CpG sites) were found to differ in iPS cell lines from the fibroblasts of origin ( Table 1,  Supplementary Table 1 ) at a false discovery rate (FDR) of 5%; we term these regions RDMRs. Of these RDMRs, DMRs that were hypermethylated in iPS cells compared to fibroblasts predominated over hypomethylated DMRs (60%:40%). Of the 4,401 DMRs, 1,969 were within 2 kb of the transcriptional start site of a gene.
The genes that were associated with these RDMRs showed functionally important fea tures based on bioinformatic analyses. First, gene ontology (GO) annotation analysis of these genes revealed significant enrichment for genes involved in developmental and regulatory processes (Supplementary Table 2 ). For example, 38% of the genes that were hypomethylated in iPS compared to fibroblasts (P = 3.56 × 10 −60 ) and 22% of the genes that were hypermethylated in iPS compared to fibroblasts (P = 1.73 × 10 −12 ) were involved in developmental processes. To further eluci date the functional significance of these RDMRs, we looked at their overlap with bivalent domains, which mark developmental genes in embryonic stem (ES) cells 10, 11 . Notably, 65% of the RDMRs that were hypomethylated in iPS cells compared to fibroblasts showed significant association with bivalent domain marks (P < 0.0001 by 10,000 permutations), whereas only 18.6% of hypermethylated RDMRs overlapped with these domains (P = 0.5699 by 10,000 permutations) (Supplementary Table 3) . Furthermore, when we observed the overlap of the RDMRs with known binding sites for pluripotency markers such as POU5F1, NANOG and SOX2 (ref. 12), we saw a similar relationship, in which the hypomethylated RDMRs showed significant overlap (P < 0.0001 by 10,000 permutations) whereas the hypermethylated DMRs did not (P = 1 by 10,000 permu tations; Supplementary Table 4). These observations indicate that the sites of demethylation during reprogramming of fibroblasts to iPS cells are tightly linked to genes that are functionally important for pluripotency.
The RDMRs showed several noteworthy features. First, over 70% of the RDMRs were associated with CpG island shores rather than with the associated CpG islands (Fig. 1a) , regardless of whether the RDMRs were hypermethylated or hypomethylated in iPS cells rela tive to fibroblasts (Supplementary Fig. 1a) . Second, 56% of RDMRs overlapped TDMRs previously identified as distinguishing tissues representing the three germ cell lineages, namely, brain, liver and spleen 8 ( Table 1) . This overlap was statistically significant (P < 0.0001 by 10,000 permutations). Furthermore, both hypermethylated and hypomethylated RDMRs in iPS cells showed similar overlap with known TDMRs, overlapping at 54% and 60%, respectively ( Table 1) . Thus, RDMRs are heavily enriched in CpG island shores and largely overlap TDMRs that are involved in normal development. There was also a 61% overlap of the geneproximal RDMRs with the TDMRs.
We then repeated the CHARM analysis on a separate set of three iPS cell lines and the fibroblasts from which they were derived, as well as three human ES cell lines. We could not perform an FDR sta tistical test on this smaller number of lines, so we used a similar area cutoff in the curves that corresponded in magnitude to the 5% FDR cutoff of the previous experiment. In this second analysis, 2,179 R DMRs were identified, with a slight excess of hypomethylated versus hypermethylated DMRs (55% compared to 45%) in iPS cells. Notably, 80% of the DMRs overlapped those found in the first experiment Chr. 14 94,306,000 94,308,000 94,310,000 94,312,000 l e t t e r s (see Supplementary Table 5 for full list). As in the first analysis, there was a substantial enrichment for CpG island shores (78%, Supplementary  Fig. 1b) , and 60% of the RDMRs overlapped TDMRs ( Table 1) . This second analysis provided insight into the methylome of iPS cells as compared to ES cells. Although the two cell types had very sim ilar DNA methylation, 71 DMRs distinguished them, with 51 show ing hypermethylation and 20 showing hypomethylation in iPS cells (Supplementary Table 6 ). GO annotation of these DMRs showed sig nificant enrichment of developmental processes in the genes that were hypermethylated in iPS cells as compared to ES cells (Supplementary Table 7 ). In 32 of the DMRs that distinguish iPS cells from ES cells, the DMRs were near genes of interest, including HOXA9 and two genes that encode the zinc finger proteins ZNF568 and ZFP112. In some cases, the methylation in iPS cells was intermediate between differentiated fibroblasts and ES cells; this was true, for example, of TBX5, which encodes a transcription factor that is involved in cardiac and limb development. In other cases, methylation in iPS cells dif fered from both fibroblasts and ES cells, suggesting that the iPS cells occupy a distinct and possibly aberrant epigenetic state. An exam ple was PTPRT, encoding a protein tyrosine phosphatase involved in many cellular processes including differentiation. For some ESiPS differences, the methylation levels changed in the same direc tion as for ES cells compared to fibroblasts, but to a greater degree; for example, methylation of the homeobox gene HOXA9 was greater in iPS compared to ES, whose methylation at this gene was greater than in fibroblasts.
We validated these data in two ways. First we verified the methyla tion results from CHARM by bisulfite pyrosequencing of nine DMRs, examining 2-6 CpGs within each DMR. For all of these genes, the bisulfite pyrosequencing data confirmed the differential methylation data from CHARM (Fig. 1b,c, Supplementary Fig. 2) .
We also performed global gene expression analysis using the Affymetrix HGU133 Plus 2.0 microarray. There was a strong inverse correlation between differential gene expression and differential DNA methylation at RDMRs that are within 500 bp of the transcriptional start site (TSS) of a gene: P < 10 −3 for both hypermethylation and hypomethylation ( Supplementary Fig. 3a, Supplementary Table 8) . The significant association held true even when the RDMR was within 1 kb of a TSS (P = 0.01 and P < 10 −3 for hypermethylated and hypomethylated RDMRs, respectively, Supplementary Fig. 3b) . Moreover, this cor relation was enhanced in DMRs that were in CpG island shores.
Furthermore, we performed an unsuper vised cluster analysis using the RDMRs to determine to what degree the methylation at these locations distinguished normal brain, liver and spleen from each other. Notably, there was complete separation of these three tissues, indicating that the sites of the meth ylation changes that occur during reprogram ming normally distinguish these disparate tissues (Fig. 2a) . In addition, the RDMRs could largely distinguish normal colonic mucosa from colorectal cancer, indicating that the RDMRs are also involved in abnor mal reprogramming in cancer (Fig. 2b) . As a test of significance, none of 1,000 randomly generated lists of the CHARM array regions of equal length and number clustered the tissues as well, as assessed either by whether they yielded a median euclidean distance among samples of a given tissue type at least as low as that found when using the RDMRs, or yielded a median euclidean distance among samples of different tissue types at least as great as that found when using the RDMRs. This was true both for the comparison between normal tissues and for the cancertonormaltissue comparison.
We compared the RDMRs to those obtained in a genomescale comparison of DNA methylation in colorectal cancer and matched normal colonic mucosa from the same individuals (CDMRs) 8 . We had previously found a much smaller number of CDMRs than TDMRs (2,707 compared to 16,379), and 45% of the CDMRs overlapped TDMRs. Approximately 16% of the RDMRs in the present study overlapped the CDMRs of the previous study, whereas only 4.5% on average would be predicted by permutation analysis to overlap (P < 0.0001 based on 10,000 permutations) (Supplementary Table 9) . Notably, hypomethylated RDMRs (iPS compared to fibroblasts) were associated with hypermethylated CDMRs (cancer compared to normal, P < 0.0001 based on 10,000 permutations) (Supplementary Table 9 ). Of the 294 DMRs found to overlap between hypomethylated RDMRs and hypermethylated CDMRs, 251 (85%) also overlapped bivalent chromatin marks. In contrast, hypermethylated RDMRs were associated with hypomethylated CDMRs (P < 0.0001 based on 10,000 permutations) (Supplementary Table 9 ). Of the 293 DMRs found to overlap between hypermethylated RDMRs and hypometh ylated CDMRs, only 37 (13%) also overlapped bivalent chromatin marks. Because bivalent chromatin marks are associated with recruit ment of Polycomb group proteins, these data suggest that there are two independent epigenetic mechanisms for cell reprogramming and tumorigenesis. One mechanism involves decreased DNA methylation and chromatin modifications at bivalent sites during reprogramming and increased methylation in cancer. The other mechanism involves increased methylation during reprogramming and loss of methyla tion in cancer.
In summary, we have found that epigenetic reprogramming of human fibroblasts to iPS cells involves substantial changes in DNA methylation largely affecting the same CpG island shores in TDMRs that mark normal differentiation. It is notable that the RDMRs com pletely distinguish brain from liver from spleen tissues and largely distinguish colon cancer from normal colon tissue. These results 
l e t t e r s l e t t e r s
provide compelling evidence of the importance of CpG island shores and TDMRs in both normal development and somatic cell repro gramming. Indeed, the target loci for normal tissue programming, epigenetic reprogramming to pluripotency and aberrant program ming of cancers largely overlap. A secondary finding is that certain loci in iPS cells remain incompletely reprogrammed, whereas others are aberrantly reprogrammed, thus establishing that the methylation pattern of iPS cells differs both from those of the parent somatic cells and from those of human ES cells. Our results contrast with prior studies that were primarily directed toward developing powerful new tools to analyze DNA methylation of targeted genomic regions rather than genomescale studies of iPS cell methylation. Our more extensive genomescale analysis of nine paired sets of iPS cells and parental fibroblasts detected roughly equal levels of hypo and hypermethylation and revealed the pre dominant involvement of CpG island shores over islands themselves. Limitations of our study include the stillincomplete genome coverage of the CHARM array, which although including islands and shores, still does not examine single or very low density CpG methylation; the use of iPS cells derived from a single cell type; and the still rela tively limited database for comparison of TDMRs, involving only three normal tissue types, and CDMRs, involving only one cancer type. Nevertheless, the present study reveals a host of loci that repre sent targets of epigenetic remodeling that are central to somatic cell reprogramming. These RDMRs include both hypomethylated and hypermethylated regions and are a subset of the previously described TDMRs and CDMRs, indicating that these RDMRs at CpG island shores are critical epigenetic targets for defining cell fate.
Finally, the colocalization of hypomethylated RDMRs in iPS cells with hypermethylated CDMRs in cancer and bivalent chromatin marks, and hypermethylated RDMRs with hypomethylated CDMRs and the absence of these marks, suggest two parallel mechanisms for epigenetic reprogramming in iPS cells and in cancer, one involving a loss of DNA methylation in iPS and a chromatindependent gain of DNA methyla tion in cancer and the other involving a gain of methylation in iPS and a chromatinindependent loss of DNA methylation in cancer.
MeTHoDS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Accession codes. NCBI GEO: Gene expression microarray data and CHARM microarray data have been submitted under accession number GSE18111. Notably, all of the normal brain, spleen and liver tissues are completely discriminated by the regions that differ between iPS cells and fibroblasts (R-DMRs). The major branches in the dendrograms correspond perfectly to tissue type. Furthermore, most of the colorectal cancer samples are discriminated from matched normal colonic mucosa by R-DMRs.
